90 related articles for article (PubMed ID: 18458575)
1. Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital.
da Costa Moraes CA; Trompieri NM; Cavalcante Felix FH
J Pediatr Hematol Oncol; 2008 May; 30(5):387-90. PubMed ID: 18458575
[TBL] [Abstract][Full Text] [Related]
2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
4. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
6. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
Dorantes-Acosta E; Medina-Sanson A; Jaimes-García Y; López-Martínez B
Rev Invest Clin; 2013; 65(5):392-8. PubMed ID: 24687338
[TBL] [Abstract][Full Text] [Related]
8. [Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia].
Bargetzi MJ; Tichelli A; Gratwohl A; Speck B
Schweiz Med Wochenschr; 1996 Nov; 126(45):1944-5. PubMed ID: 8946598
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
Bergstrom SK; Gillan E; Quinn JJ; Altman AJ
J Pediatr Hematol Oncol; 1998; 20(6):545-7. PubMed ID: 9856675
[TBL] [Abstract][Full Text] [Related]
10. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute promyelocytic leukemia with trans-retinoic acid. Experience of the Santa Maria Hospital, Medical School of Lisbon].
De Lacerda JF; Do Carmo JA; De Moura MC; Guerra ML; Lopes C; Raposo J; Melo A; De Oliveira JJ; De Lacerda JM
Acta Med Port; 1994 Dec; 7(12):717-24. PubMed ID: 7717119
[TBL] [Abstract][Full Text] [Related]
13. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
[TBL] [Abstract][Full Text] [Related]
14. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
Notario A; Rolandi ML; Mazzucchelli I
Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
Castaigne S; Degos L
C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
[TBL] [Abstract][Full Text] [Related]
18. [Induction and maintenance therapy in all-trans retinoic acid with relapsed acute promyelocytic leukemia].
Takitani K; Kawamura N; Yamaguchi H; Morinobu W; Yoshida N; Watanabe K; Miyake M; Tatsumi K; Mino M
Rinsho Ketsueki; 1995 Feb; 36(2):147-52. PubMed ID: 7715086
[TBL] [Abstract][Full Text] [Related]
19. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]